[Butalamine hydrochloride. A new vasoactive substance].
With its new mode of action Adrevil has a stimulating effect on the blood flow, without affecting the cardiovascular system. Oxygen supply in the diseased vascular areas is improved. The antiphlogistic and analgetic properties of the drug as well as its local anaesthetic effect favourably influence painful, inflammatory and proliferative processes in the ischemic areas. In view of its effectiveness at low doses and its very low toxicity Adrevil is considered a most effective therapeutic agent to be used in a large range of indications. No teratogenic effect of the substance was observed in animal experiments.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects; D051379:Mice; D009132:Muscles / Q000187:drug effects; D010069:Oxadiazoles / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects
D010069:Oxadiazoles
Butalaminhydrochlorid. Eine neue vasoaktive Monosubstanz